Form 4: MacroGenics Inc. Executive Sells Shares Under 10b5-1 Trading Plan

Jeffrey Stuart Peters, Senior VP and General Counsel of MacroGenics Inc., sold 16,124 shares of common stock at an average price of $17.22 on February 26, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• On February 26, 2024, Jeffrey Stuart Peters, Senior VP and General Counsel of MacroGenics Inc. (MGNX), sold 16,124 shares of common stock.
• The sale was executed at a price of $17.22 per share.
• The transaction was conducted under a Rule 10b5-1 trading plan adopted on November 10, 2022.
• Following the transaction, Peters directly owns 8,895 shares of MacroGenics Inc.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it's a routine disclosure of an insider sale under a pre-arranged trading plan. It doesn't necessarily indicate a positive or negative outlook for the company.

Industry Context

This filing is a routine disclosure of an insider transaction. It's common for executives to use 10b5-1 trading plans to sell shares over time to avoid accusations of insider trading. The impact on the stock price is usually minimal unless the sale is unusually large or coincides with other significant news.

Stakeholder Impact

• The sale of shares by an executive could be perceived negatively by some shareholders, but the existence of a 10b5-1 plan mitigates this concern.

Key Dates